Plné znění - 261/2015 Sb.

Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2016

261/2015 Sb.

Sdělení Ministerstva zdravotnictví

INFORMACE

261

XXXXXXX

Xxxxxxxxxxxx zdravotnictví

ze dne 22. xxxx 2015

x xxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxxxx, xxxxxxxx x mimořádná xxxxxxxx pro rok 2016

 

Xxxxxxxxxxxx zdravotnictví xxxxx §80 xxxx. 1 xxxx. x) xxxxxx x. 258/2000 Sb., x ochraně xxxxxxxxx xxxxxx x o xxxxx xxxxxxxxx souvisejících xxxxxx, ve znění xxxxxxxxxx xxxxxxxx, stanoví xx xxxxxxx xxxxxxxxxx Xxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro pravidelná, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx xxx 2016:

1. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx očkování

1a) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx forma), tetanu, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), virové xxxxxxxxxx B, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx b (XXxXXxxXXXXXX):

Xxxxxxxxxxx xxxxxxxxxx1 xx xxxx xxx 30 xxxxxxxxxxxxx xxxxxxxx (XX)

Xxxxxx xxxxxxxxxx1 xx xxxx xxx 40 xxxxxxxxxxxxx xxxxxxxx (XX)

Xxxxxxxx Xxxxxxxxxx xxxxxxxxx:

Xxxxxxxxx xxxxxxxxxx1 25 xxxxxxxxxx

Xxxxxxxxxxxxxxxx xxxxxxxxxxxx1 25 mikrogramů

Pertactinum1 8 xxxxxxxxxx

Xxxxxxxxx tegiminis xxxxxxxxxxx B2,3 10 xxxxxxxxxx

Xxxxx xxxxxxxxxxxxx (inaktivovaný)

typus 1 (kmen Xxxxxxx)4 40 X xxxxxxxx xxxxxxxx

xxxxx 2 (kmen XXX-1)4 8 X xxxxxxxx xxxxxxxx

xxxxx 3 (xxxx Xxxxxxx)4 32 X xxxxxxxx xxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx xxxxx x xxxxxxxxxxxxxxx 10 mikrogramů

(polyribosylribitoli xxxxxxxx)3

xxxxxxxxx xxx xxxxxx xxxxxxxxxx xxxx xxxxxx xxxxxxxxx xxxxxxxxx 25 xxxxxxxxxx

XXXX

1xx) kombinovaná xxxxxxxx xxxxx proti záškrtu, xxxxxxxx kašli (xxxxxxxxxx xxxxx), xxxxxx, dětské xxxxxxxx obrně (inaktivovaná xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx vyvolaným Xxxxxxxxxxx influenzae xxx x (DTaPHibVHBIPV)

Diphtheriae xxxxxxxxxx xx méně než 20 mezinárodních jednotek (XX)2

Xxxxxx xxxxxxxxxx xx xxxx xxx 40 xxxxxxxxxxxxx jednotek (XX)2

Xxxxxxxx Xxxxxxxxxx pertussis

Pertussis xxxxxxxxxx 25 mikrogramů

Haemagglutinum xxxxxxxxxxxx 25 mikrogramů

Virus Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)3

xxxxx 1 (Mahoney) 40 X xxxxxxxx xxxxxxxx4

xxxxx 2 (XXX-1) 8 D xxxxxxxx xxxxxxxx4

xxxxx 3 (Xxxxxxx) 32 D xxxxxxxx xxxxxxxx4

Xxxxxxxxx tegiminis hepatitidy X5 10 mikrogramů

Haemophilus xxxxxxxxxx typu b xxxxxxxxxxxxxxx 12 mikrogramů

(Polyribosylribitoli xxxxxxxx)

xxxxxxxxx xxx tetani xxxxxxxxxx 22-36 xxxxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), tetanu (XXxX):

Xxxxxxxxxxx xxxxxxxxxx&xxxx;≥ 30 xxxxxxxxxxxxx jednotek

Tetani xxxxxxxxxx&xxxx;≥ 40 mezinárodních xxxxxxxx

Xxxxxxxxx xxxxxxxxxx (XX) 25 xxxxxxxxxx

Xxxxxxxxx haemaglutininum filamentosum (XXX) 25 mikrogramů

Pertactinum (69xX) 8 mikrogramů

NEBO

1ba) Xxxxxxxx xxxxx proti xxxxxxx, xxxxxx a xxxxxxxx xxxxx (xxxxxxxxxx)

1 xxxxx (0,5 xx) xxxxxxxx:	Xxxxxxxxx 2 XX* (2 Xx)
Xxxxxxxxxxx xxxxxxxxxx
Xxxxxx xxxxxxxxxx	Xxxxxxxxx 20 XX* (5 Xx)
Xxxxxxxxx xxxxxxxx
Xxxxxxxxx xxxxxxxxxx	2,5 xxxxxxxxxx
Xxxxxxxxxxxxxx xxxxxxxxxxxx	5 xxxxxxxxxx
Xxxxxxxxxxx	3 mikrogramy
Fimbriae, typi 2 xx 3	5 xxxxxxxxxx
Xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx	1,5 xx (0,33 xx xxxxxxx)

XXXX

1xx) Xxxxxxxx xxxxx xxxxx záškrtu, xxxxxx x xxxxxxxx xxxxx (acelulární xxxxxxxxxx) xx sníženým xxxxxxx xxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx1 xx xxxx xxx 2 xxxxxxxxxxx xxxxxxxx (XX) (2,5 Lf)

Tetani xxxxxxxxxx1 xx méně xxx 20 xxxxxxxxxxxxx xxxxxxxx (XX) (5 Xx)

Xxxxxxxxxxx xxxxxxxxx xxxxxxxx:

Xxxxxxxxx xxxxxxxxxx1 8 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx1

8 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxx1 2,5 xxxxxxxxxx

1 xxxxxxxxxxx na xxxxxxxxxxx hydroxid xxxxxxx (XX(XX)3) 0,3 xxxxxxxxx XX3+ x xxxxxxxxxxx xxxxxxx (AIPO4) 0,2 xxxxxxxxx AI3+

1c) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), xxxxxx, xxxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxx x (XXxXXxx):

Xxxxxxxxxxx xxxxxxxxxx	xxx. 30 xxxxxxxxxxxxx xxxxxxxx
Xxxxxx xxxxxxxxxx	xxx. 40 xxxxxxxxxxxxx xxxxxxxx
Xxxxxxxxx xxxxxxxxxx (XX)	25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX)	25 xxxxxxxxxx
Xxxxxxxxxxx (69xX)	8 xxxxxxxxxx
Xxxxxxxxxxx influenzae X	10 xxxxxxxxxx
xxx xxxxxxxxx xxxxxxxx	20-40 xxxxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxxx vyvolaným Xxxxxxxxxxx xxxxxxxxxx xxx x:

1 xxxxx xxxxxxxxxxxxx xxxxxxx xxxxxxxx: Polysaccharidum Xxx purificatum (10 xxxxxxxxxx) xxx Anatoxino xxxxxxxx (25 mikrogramů).

1e) xxxxxxxx xxxxx proti xxxxxx:

Xxxxxx anatoxinum ... xxx. 40 mezinárodních xxxxxxxx

1x) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx X od 16 xxx x xxxx:

Xxxxxxxxx xxxxxxxxx hepatitidis X ... 20 mikrogramů

1g) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:

Xxxxxxxxxxx xxxxx xxxxxxxxxx (Xxxxxxx) xxx. 103,0 xxxxxxxx dávka xxx xxxxxxxx kulturu₅₀

Parotitidis xxxxx xxxxxxxxxx (XXX 4385) xxx. 103,7 infekční xxxxx pro buněčnou xxxxxxx₅₀

Xxxxxxxx xxxxx attenuatum (Xxxxxx XX 27/3) xxx. 103,0 xxxxxxxx xxxxx pro buněčnou xxxxxxx₅₀

1x) očkovací látka xxxxx xxxxxx přenosné xxxxx v xxxxxxxxxxxx xxxxx:

Xxxxx xxxxxxxxxxxxx inactivatum xxxxx 1 (Mahoney) ... 40 xxxxxxxxxxx X xxxxxxxx*

Xxxxx poliomyelitis xxxxxxxxxxx typus 2 (XXX-1) ......... 8 xxxxxxxxxxx X xxxxxxxx*

Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 3 (Saukett) ...... 32 antigenních D xxxxxxxx*

* xxxx xxxxxxxx xxxxxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxx vhodné xxxxxxxxxxxxx xxxxxx.

1xx) xxxxxxxx látka xxxxx xxxxxxx xxxxxxxxx Xxxxxxxxxxxxx pneumoniae x xxxxxxxxxxxxxxx xxxxxxx:

Xxxxxxxxxxxxxxx Xxxxxxxxxxxx xxxxxxxxxx xxxxx:

1, 2, 3, 4, 5, 6X, 7X, 8, 9X, 9X, 10X, 11X, 12X, 14, 15X, 17F, 18C, 19X, 19F, 20, 22X, 23F, 33X ... 25 xxxxxxxxxx x xxxxxxx xxxxxxxx

1x) xxxxxxxx xxxxx xxxxxxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxxx:

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 1

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 3

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 4

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 5

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 6X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6B

Pneumococcale xxxxxxxxxxxxxxx sérotypus 7F

Pneumococcale xxxxxxxxxxxxxxx sérotypus 9V

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 14

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 18X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 19X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 23X

1x) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx forma), xxxxxx, xxxxxx přenosné obrně (xxxxxxxxxxxx xxxxx):

Xxxxxxxxxxx anatoxinum	ne xxxx než 2 xxxxxxxxxxx xxxxxxxx
Xxxxxx xxxxxxxxxx	xx xxxx než 20 xxxxxxxxxxxxx jednotek

Pertusové antigeny:

Pertussis xxxxxxxxxx	8 xxxxxxxxxx
Xxxxxxxxx haemagglutinum xxxxxxxxxxxx	8 xxxxxxxxxx
Xxxxxxxxx	2,5 xxxxxxxxxx

Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:

xxxxx 1 (xxxx Xxxxxxx)	40 X xxxxxxxx xxxxxxxx
xxxxx 2 (xxxx MEF-1)	8 X xxxxxxxx xxxxxxxx
xxxxx 3 (xxxx Saukett)	32 X xxxxxxxx antigenu

NEBO

1ja) xxxxxxxx xxxxx xxxxx záškrtu, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), tetanu, xxxxxx xxxxxxxx xxxxx (inaktivovaná xxxxx):

Xxxxxxxxxx toxoid	více xxxx xxxxx 2 xxxxxxxxxxx xxxxxxxx (2 Xx)
Xxxxxxxxx xxxxxx	xxxx nebo xxxxx 20 xxxxxxxxxxxxx xxxxxxxx (5 Xx)

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxx xxxxxx	2,5 mikrogramu
Filamentózní xxxxxxxxxxxx	5 xxxxxxxxxx
Xxxxxxx xxxx 2+3	5 xxxxxxxxxx
Xxxxxxxxx	3 mikrogramy

-

Virus xxxxxxxxxxxxx xxxx 1 (xxxxxxxxxxxx)	40 xxxxxxxxxxx D jednotek
Virus xxxxxxxxxxxxx xxxx 2 (xxxxxxxxxxxx)	8 antigenních D xxxxxxxx
Xxxxx poliomyelitis xxxx 3 (xxxxxxxxxxxx)	32 xxxxxxxxxxx X jednotek

1l) očkovací xxxxx xxxxx xxxxxxxxxxx:

Xxxxxxxxxxxxx xxxxx xxxxxxxxxx (BCG) xxxxxxx Xxxxxxx 1331.....0,75 xx

&xx;2,0 x 10⁶ ≤ 8,0 x 10⁶ XXX (xxxxxx xxxxxxx)

1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X pro xxxxx xxxxxxxx xx xxxxxxxxxxxx xxxxxxxx:

Xxxxxxxxx tegiminis hepatitidis X xxxxxxxxxxxxxx 20 xxxxxxxxxx; xxxxxxxx XX04X xxxxxxxxxx 3-O-deacyl-4-monofosforyl-lipid X (XXX) 50 xxxxxxxxxx x 1 xxxxx

1x) Xxxxxxxx látka proti xxxxxx xxxxxxxxxx X x xxxxxx xxxxxxx:

Xxxxxxxxx xxxxxxxxx hepatitidis X 10 xxxxxxxxxx v 0,5 ml suspenze

2. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx zvláštní xxxxxxxx

2x) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx X xx formuli xxx xxxxxxx:

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X ... 20 xxxxxxxxxx

2x) xxxxxxxx látka xxxxx xxxxxxxxx

Xxxxx rabiei inactivatum (xxxx Wistar xxxxxx XX/XX 38&xxxx;1503-3X xxxx xxxx rovno 2,5 xxxxxxxxxxxxx xxxxxxxx x 1 dávce (0,5 xx)

2x) xxxxxxxx látka xxxxx virové hepatitidě X xx xxxxxxx xxx xxxxxxx:

Xxxxxxxxx X xxxxx xxxxxxxxxxx

3. Antigenní xxxxxxx očkovacích xxxxx xxx mimořádná xxxxxxxx

3x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx xxxxxxx:

Xxxxxxxxx X virus xxxxxxxxxxx

3x) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx X xx xxxxxxx xxx děti:

Virus hepatitis X xxxxxxxxxxx

 

X xxxx 2016 s xxxxxxx xx xxxxxxxxxx xxxxxxxxxx xxxxxxxx č. 537/2006 Sb., o xxxxxxxx xxxxx infekčním xxxxxxx, ve znění xxxxxxxxxx předpisů, xxxxx xxxxxxxx xxxxxxxxx úpravu xxxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro pravidelná xxxxxxxx xxxxxxxxxxxx xxxxxx xxxxxxxxxxx složení xxxxxx xxxxxxxxxx xxxxx xx Xxxxxx xxxxxx.

 

Xxxxxxx:

x x. XXXx. Xxxxxxx v. x.

xxxxxxxx xxx xxxxxxxxxxx x xxxxx

Xxxxxxxxx

Xxxxxx xxxxxxx x. 261/2015 Xx. xxxxx xxxxxxxxx xxxx 24.10.2015.

Xx xxxxx xxxxxx xxxxxxxx xxxxxxxx xxxx xxxxxxxxxx xxxxx x xxxxxxxx xxxxxxxxxxx právním xxxxxxxxx x.:

131/2016 Xx., kterým xx xxxx xxxxxxx x. 261/2015 Xx., x xxxxxxxxxx složení xxxxxxxxxx látek xxx xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx pro xxx 2016

x xxxxxxxxx xx 10.5.2016

Xxxxx xxxxxxxxxxxx xxxxxxxx norem xxxxxx xxxxxxxx předpisů x xxxxxxxx není aktualizováno, xxxxx xx xxxx xxxxxx xxxxxxxxx změna xxxxx xxxxxxxxx právního xxxxxxxx.